121 related articles for article (PubMed ID: 30600205)
21. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles.
Kamal A; Hussaini SM; Faazil S; Poornachandra Y; Narender Reddy G; Kumar CG; Rajput VS; Rani C; Sharma R; Khan IA; Jagadeesh Babu N
Bioorg Med Chem Lett; 2013 Dec; 23(24):6842-6. PubMed ID: 24206766
[TBL] [Abstract][Full Text] [Related]
22. An improved synthesis of psammaplin A.
Godert AM; Angelino N; Woloszynska-Read A; Morey SR; James SR; Karpf AR; Sufrin JR
Bioorg Med Chem Lett; 2006 Jun; 16(12):3330-3. PubMed ID: 16632351
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antimicrobial activity of new substituted 1,2,4-triazoles and their acyclic C-nucleoside analogues.
El-Sayed WA; Ali OM; El-Dakkony SR; Abdel-Rahman AA
Z Naturforsch C J Biosci; 2010; 65(1-2):15-21. PubMed ID: 20355315
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and structure elucidation of some 4-substituted benzylidene amino-5-[3(5)-methyl-5(3)-phenyl-1H-1-pyrazolyl]-2,4-dihydro-3H-1,2,4- triazole-3-thione derivatives with their antimicrobial activities.
Doğan HN; Büyüktimkin S; Rollas S; Yemni E; Cevikbaş A
Farmaco; 1997; 52(8-9):565-8. PubMed ID: 9507666
[TBL] [Abstract][Full Text] [Related]
25. Fluorescent analogs of the marine natural product psammaplin A: synthesis and biological activity.
Hentschel F; Sasse F; Lindel T
Org Biomol Chem; 2012 Sep; 10(35):7120-33. PubMed ID: 22872318
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, biological evaluation and molecular modeling studies of psammaplin A and its analogs as potent histone deacetylases inhibitors and cytotoxic agents.
Wen J; Bao Y; Niu Q; Liu J; Yang J; Wang W; Jiang T; Fan Y; Li K; Wang J; Zhao L; Liu D
Bioorg Med Chem Lett; 2016 Sep; 26(17):4372-6. PubMed ID: 27460171
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological action of 1-aminomethyl derivatives of 3-R-4-phenyl-delta2-1,2,4-triazoline-5-thione.
Pitucha M; Wujec M; Dobosz M; Kosikowska U; Malm A
Acta Pol Pharm; 2005; 62(6):443-9. PubMed ID: 16583983
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and antimicrobial potential of nitrofuran-triazole congeners.
Kamal A; Hussaini SM; Sucharitha ML; Poornachandra Y; Sultana F; Ganesh Kumar C
Org Biomol Chem; 2015 Sep; 13(36):9388-97. PubMed ID: 26238045
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and in vitro activity of 1,2,4-triazole-ciprofloxacin hybrids against drug-susceptible and drug-resistant bacteria.
Plech T; Wujec M; Kosikowska U; Malm A; Rajtar B; Polz-Dacewicz M
Eur J Med Chem; 2013 Feb; 60():128-34. PubMed ID: 23287058
[TBL] [Abstract][Full Text] [Related]
30. The effect of systematic structural modifications on the antibacterial activity of novel oxazolidinones.
Pintér G; Bereczki I; Roth E; Sipos A; Varghese R; Udo EE; Ostorházi E; Rozgonyi F; Phillips OA; Herczegh P
Med Chem; 2011 Jan; 7(1):45-55. PubMed ID: 21235519
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, antibacterial properties and 2D-QSAR studies of quinolone-triazole conjugates.
Faidallah HM; Girgis AS; Tiwari AD; Honkanadavar HH; Thomas SJ; Samir A; Kalmouch A; Alamry KA; Khan KA; Ibrahim TS; Al-Mahmoudy AMM; Asiri AM; Panda SS
Eur J Med Chem; 2018 Jan; 143():1524-1534. PubMed ID: 29126731
[TBL] [Abstract][Full Text] [Related]
32. Click chemistry approach for bis-chromenyl triazole hybrids and their antitubercular activity.
Naik RJ; Kulkarni MV; Sreedhara Ranganath Pai K; Nayak PG
Chem Biol Drug Des; 2012 Oct; 80(4):516-23. PubMed ID: 22737986
[TBL] [Abstract][Full Text] [Related]
33. Antibacterial effects of some 1-substituted 1,2,4-triazoles.
Jantová S; Greif G; Pavlovicová R; Cipák L
Folia Microbiol (Praha); 1998; 43(1):75-8. PubMed ID: 9569632
[TBL] [Abstract][Full Text] [Related]
34. New synthetic strategies towards psammaplin A, access to natural product analogues for biological evaluation.
Baud MG; Leiser T; Meyer-Almes FJ; Fuchter MJ
Org Biomol Chem; 2011 Feb; 9(3):659-62. PubMed ID: 21113514
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and antimicrobial activity of N-[(alpha-methyl)benzylidene]-(3-substituted-1,2,4-triazol-5-yl-thio) acetohydrazides.
Ersan S; Nacak S; Berkem R
Farmaco; 1998 Dec; 53(12):773-6. PubMed ID: 10230058
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and antimicrobial evaluation of naphtho[2,1-b]pyrano[2,3-d]pyrimidine and pyrano[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives.
Eid FA; Abd El-Wahab AH; Ali GA; Khafagy MM
Acta Pharm; 2004 Mar; 54(1):13-26. PubMed ID: 15050041
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, cytotoxicity, antimicrobial and anti-biofilm activities of novel pyrazolo[3,4-b]pyridine and pyrimidine functionalized 1,2,3-triazole derivatives.
Nagender P; Malla Reddy G; Naresh Kumar R; Poornachandra Y; Ganesh Kumar C; Narsaiah B
Bioorg Med Chem Lett; 2014 Jul; 24(13):2905-8. PubMed ID: 24835633
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of novel triazole/isoxazole functionalized 7-(trifluoromethyl)pyrido[2,3-d]pyrimidine derivatives as promising anticancer and antibacterial agents.
Naresh Kumar R; Jitender Dev G; Ravikumar N; Krishna Swaroop D; Debanjan B; Bharath G; Narsaiah B; Nishant Jain S; Gangagni Rao A
Bioorg Med Chem Lett; 2016 Jun; 26(12):2927-2930. PubMed ID: 27130357
[TBL] [Abstract][Full Text] [Related]
39. Convenient framework of poly functionalized (E)-2-benzylideno-(Z)-carbazolylideno cyanoacetamides via rearrangements as an efficient antibiofilm inhibitors with SAR study.
Sathiyachandran P; Jayamanoharan J; Nesterov VN; Prasad KJR
Bioorg Med Chem; 2019 Mar; 27(5):777-784. PubMed ID: 30692023
[TBL] [Abstract][Full Text] [Related]
40. Imidazo- and triazoloquinolones as antibacterial agents. Synthesis and structure-activity relationships.
Fujita M; Egawa H; Kataoka M; Miyamoto T; Nakano J; Matsumoto J
Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2123-32. PubMed ID: 8582014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
